Ovarian
Featured Articles
(Medscape Medical News) June 20, 2017 - While it has been well established that carriers of the BRCA1 and BRCA2 mutations face a higher risk for breast and ovarian cancer, most studies to date have been retrospective.
Read Article
(Morningstar) June 19, 2017 - Clovis Oncology, Inc. today announced topline data from the confirmatory phase 3 ARIEL3 trial of rucaparib, which successfully achieved the primary endpoint of improved progression-free survival (PFS) by investigator review in each of the three populations studied.
Read Article
Latest Articles
June 19, 2017
June 19, 2017
June 19, 2017
June 19, 2017
June 08, 2017
June 08, 2017
June 07, 2017
June 05, 2017
View More
News Commentary
There is no Ovarian commentary.

OBR Green
There are no Ovarian OBR Green articles.
Featured Videos
There are no videos.
OBR Blog
There are no Ovarian blog entries.